Table 5.

Clinical characteristics of patients in survival analysis

CharacteristicsNo. event, n (%)No. recurrence/death, n (%)
No. subjects52927
Median age at diagnosis, y (range)45 (22-82)44 (34-76)
Stage (AJCC)
I23 (4.3)0 (0.0)
II475 (89.0)21 (80.8)
III27 (5.1)3 (11.5)
IV9 (1.7)2 (7.7)
T stage
023 (4.3)0 (0.0)
I244 (45.6)9 (34.6)
II234 (43.7)13 (50.0)
III24 (4.5)2 (7.7)
IV10 (1.9)2 (7.7)
Lymph node status
Negative331 (61.8)6 (22.2)
Positive205 (38.2)21 (77.8)
Distant metastasis9 (1.7)2 (7.7)
ER
Positive316 (62.1)7 (29.2)
Negative193 (37.9)17 (70.8)
PR
Positive230 (45.2)4 (16.7)
Negative279 (54.8)20 (83.3)
Median F/U duration, mos (range)13.6 (3.8-73.3)17.4 (3.8-28.3)